Short stature due to primary acid-labile subunit deficiency (Q106514): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Baixa estatura devido à deficiência primária da subunidade ácido-lábil é definida por moderado déficit de crescimento pós-natal, níveis séricos do fator de crescimento semelhante a insulina 1 (IGF-1) muito baixos e proteína de ligação ao fator de crescimento semelhante à insulina tipo 3 (IGFBP-3) e hiperinsulinemia, na ausência de deficiência de hormônio do crescimento (GH) ou insensibilidade ao GH. | |||
| description / en | description / en | ||
Short stature due to primary acid-labile subunit (ALS) deficiency is defined by moderate postnatal growth deficit, markedly low circulating levels of insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3), and hyperinsulinemia, in the absence of growth hormone (GH) deficiency or GH insensitivity. | |||
Revision as of 13:30, 17 August 2026
Short stature due to primary acid-labile subunit (ALS) deficiency is defined by moderate postnatal growth deficit, markedly low circulating levels of insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3), and hyperinsulinemia, in the absence of growth hormone (GH) deficiency or GH insensitivity.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_29735645 |
||
| English | Short stature due to primary acid-labile subunit deficiency |
Short stature due to primary acid-labile subunit (ALS) deficiency is defined by moderate postnatal growth deficit, markedly low circulating levels of insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3), and hyperinsulinemia, in the absence of growth hormone (GH) deficiency or GH insensitivity. |
